Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

379 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment.
Sakuraba A, Motoya S, Watanabe K, Nishishita M, Kanke K, Matsui T, Suzuki Y, Oshima T, Kunisaki R, Matsumoto T, Hanai H, Fukunaga K, Yoshimura N, Chiba T, Funakoshi S, Aoyama N, Andoh A, Nakase H, Mizuta Y, Suzuki R, Akamatsu T, Iizuka M, Ashida T, Hibi T. Sakuraba A, et al. Among authors: aoyama n. Am J Gastroenterol. 2009 Dec;104(12):2990-5. doi: 10.1038/ajg.2009.453. Epub 2009 Sep 1. Am J Gastroenterol. 2009. PMID: 19724269 Clinical Trial.
A multicenter study of the efficacy and safety of leukocytapheresis therapy without concomitant systemic steroid treatment in patients with active ulcerative colitis.
Ashida T, Kohgo Y, Munakata A, Noguchi M, Iizuka B, Endo Y, Hanai H, Yoshikawa T, Matsumoto T, Aoyama N, Matsui T, Mitsuyama K, Hibi T. Ashida T, et al. Among authors: aoyama n. Transfus Apher Sci. 2011 Apr;44(2):113-7. doi: 10.1016/j.transci.2011.01.001. Transfus Apher Sci. 2011. PMID: 21402309 Clinical Trial.
Correction to: Complete mucosal healing of distal lesions induced by twice-daily budesonide 2-mg foam promoted clinical remission of mild-to-moderate ulcerative colitis with distal active inflammation: double-blind, randomized study.
Naganuma M, Aoyama N, Tada T, Kobayashi K, Hirai F, Watanabe K, Watanabe M, Hibi T. Naganuma M, et al. Among authors: aoyama n. J Gastroenterol. 2018 Apr;53(4):579-581. doi: 10.1007/s00535-017-1399-x. J Gastroenterol. 2018. PMID: 29027564 Free PMC article.
A large-scale nationwide multicenter prospective observational study of triple therapy using rabeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in Japan.
Fujioka T, Aoyama N, Sakai K, Miwa Y, Kudo M, Kawashima J, Matsubara Y, Miwa J, Yakabi K. Fujioka T, et al. Among authors: aoyama n. J Gastroenterol. 2012 Mar;47(3):276-83. doi: 10.1007/s00535-011-0487-6. Epub 2011 Nov 9. J Gastroenterol. 2012. PMID: 22065160 Clinical Trial.
Complete mucosal healing of distal lesions induced by twice-daily budesonide 2-mg foam promoted clinical remission of mild-to-moderate ulcerative colitis with distal active inflammation: double-blind, randomized study.
Naganuma M, Aoyama N, Tada T, Kobayashi K, Hirai F, Watanabe K, Watanabe M, Hibi T. Naganuma M, et al. Among authors: aoyama n. J Gastroenterol. 2018 Apr;53(4):494-506. doi: 10.1007/s00535-017-1376-4. Epub 2017 Aug 4. J Gastroenterol. 2018. PMID: 28779419 Free PMC article. Clinical Trial.
Recurrent peptic ulcers in patients following successful Helicobacter pylori eradication: a multicenter study of 4940 patients.
Miwa H, Sakaki N, Sugano K, Sekine H, Higuchi K, Uemura N, Kato M, Murakami K, Kato C, Shiotani A, Ohkusa T, Takagi A, Aoyama N, Haruma K, Okazaki K, Kusugami K, Suzuki M, Joh T, Azuma T, Yanaka A, Suzuki H, Hashimoto H, Kawai T, Sugiyama T. Miwa H, et al. Among authors: aoyama n. Helicobacter. 2004 Feb;9(1):9-16. doi: 10.1111/j.1083-4389.2004.00194.x. Helicobacter. 2004. PMID: 15156899
Leukocytapheresis therapy for steroid-naïve patients with active ulcerative colitis: its clinical efficacy and adverse effects compared with those of conventional steroid therapy.
Nishioka C, Aoyama N, Maekawa S, Shirasaka D, Nakahara T, Tamura T, Fukagawa M, Umezu M, Abe T, Kasuga M. Nishioka C, et al. Among authors: aoyama n. J Gastroenterol Hepatol. 2005 Oct;20(10):1567-71. doi: 10.1111/j.1440-1746.2005.03907.x. J Gastroenterol Hepatol. 2005. PMID: 16174075 Clinical Trial.
Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan.
Miki I, Aoyama N, Sakai T, Shirasaka D, Wambura CM, Maekawa S, Kuroda K, Tamura T, Kita T, Sakaeda T, Okumura K, Kasuga M. Miki I, et al. Among authors: aoyama n. Eur J Gastroenterol Hepatol. 2003 Jan;15(1):27-33. doi: 10.1097/00042737-200301000-00006. Eur J Gastroenterol Hepatol. 2003. PMID: 12544691 Clinical Trial.
379 results